This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Successful Use of Phenelzine in Treatment-Resistant Panic Disorder

Sandip Buch, MD, and Michael Wagner, MD

Published: February 15, 2007

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Paroxetine, fluoxetine, sertraline, venlafaxine, clonazepam, and alprazolam are currently the only medications approved by the U.S. Food and Drug Administration for the treatment of panic disorder. In practice, first-line treatment usually involves selective serotonin reuptake inhibitors (SSRIs). Other treatment options might include tricyclic antidepressants (most commonly clomipramine and imipramine), venlafaxine, buspirone, nefazodone, β-blockers, and monoamine oxidase inhibitors (MAOIs).’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 68

Quick Links: Anxiety , Panic Disorder

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...